Chronic Lymphocytic Leukemia-The Price of Progress

被引：9

作者：

Shanafelt, Tait D. ^{[1
]}

Gunderson, Heidi ^{[1
]}

Call, Timothy G. ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN 55905 USA

来源：

ONCOLOGIST | 2010年 / 15卷 / 06期

关键词：

UNTREATED PATIENTS; RITUXIMAB; CHEMOIMMUNOTHERAPY; CYCLOPHOSPHAMIDE; FLUDARABINE;

D O I：

10.1634/theoncologist.2010-0090

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial bias. No financial relationships relevant to the content of this article have been disclosed by the independent peer reviewers.

引用

页码：601 / 602

页数：2

共 6 条

[1] Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712) [J].

Byrd, JC ;

Peterson, BL ;

Morrison, VA ;

Park, K ;

Jacobson, R ;

Hoke, E ;

Vardiman, JW ;

Rai, K ;

Schiffer, CA ;

Larson, RA .

BLOOD, 2003, 101 (01) :6-14

[2] Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia [J].

Foon, Kenneth A. ;

Boyiadzis, Michael ;

Land, Stephanie R. ;

Marks, Stanley ;

Raptis, Anastasios ;

Pietragallo, Louis ;

Meisner, Dennis ;

Laman, Andrew ;

Sulecki, Mathew ;

Butchko, Allyson ;

Schaefer, Patricia ;

Lenzer, Diana ;

Tarhini, Ahmad .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) :498-503

[3]

Hallek M., 2009, Blood. ASH Annual Meeting Abstracts, V114, P535, DOI [10.1182/blood.V114.22.535.535, DOI 10.1182/BLOOD.V114.22.535.535]

[4] Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia [J].

Kay, Neil E. ;

Geyer, Susan M. ;

Call, Timothy G. ;

Shanafelt, Tait D. ;

Zent, Clive S. ;

Jelinek, Diane F. ;

Tschumper, Renee ;

Bone, Nancy D. ;

Dewald, Gordon W. ;

Lin, Thomas S. ;

Heerema, Nyla A. ;

Smith, Lisa ;

Grever, Michael R. ;

Byrd, John C. .

BLOOD, 2007, 109 (02) :405-411

[5] Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia [J].

Keating, MJ ;

O'Brien, S ;

Albitar, M ;

Lerner, S ;

Plunkett, W ;

Giles, F ;

Andreeff, M ;

Cortes, J ;

Faderl, S ;

Thomas, D ;

Koller, C ;

Wierda, W ;

Detry, MA ;

Lynn, A ;

Kantarjian, H .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) :4079-4088

[6]

Rai KR., 2009, BLOOD, V114, P536, DOI DOI 10.1182/BLOOD.V114.22.536.536

← 1 →